Ulf Gerdtham
Professor
Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective : results from a prospective intervention study
Författare
Summary, in English
Background:The delay between onset of macroscopic haematuria and diagnosis of bladder cancer is often long.Methods:We evaluated timely diagnosis and health-care costs for patients with macroscopic haematuria given fast-track access to diagnostics. During a 15-month period, a telephone hotline for fast-track diagnostics was provided in nine Swedish municipalities for patients aged ⩾50 years with macroscopic haematuria. The control group comprised 101 patients diagnosed with bladder cancer in the same catchment area with macroscopic haematuria who underwent regular diagnostic process.Results:In all 275 patients who called ‘the Red Phone’ hotline were investigated, and 47 of them (17%) were diagnosed with cancer and 36 of those had bladder cancer. Median time from patient-reported haematuria to diagnosis was 29 (interquartile range (IQR) 14−104) days and 50 (IQR 27−165) days in the intervention and the control group, respectively (P=0.03). The median health-care costs were lower in the intervention group (655 (IQR 655−655) EUR) than in the control group (767 (IQR 490−1096) EUR) (P=0.002).Conclusions:Direct access to urologic expertise and fast-track diagnostics is motivated for patients with macroscopic haematuria to reduce diagnostic intervals and lower health-care expenditures.British Journal of Cancer advance online publication, 25 August 2016; doi:10.1038/bjc.2016.265 www.bjcancer.com.
Avdelning/ar
- EpiHealth: Epidemiology for Health
- Urologi - blåscancer, Malmö
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- Bröstcancer-genetik
- Hälsoekonomi
- Urologi
- Medicinsk onkologi
Publiceringsår
2016-08-25
Språk
Engelska
Sidor
770-775
Publikation/Tidskrift/Serie
British Journal of Cancer
Volym
115
Dokumenttyp
Artikel i tidskrift
Förlag
Nature Publishing Group
Ämne
- Urology and Nephrology
- Cancer and Oncology
Nyckelord
- urologic care
- macroscopic haematuria
Status
Published
Projekt
- Precision Medicine in Hereditary Cancer and Sarcoma; targeted surveillance, immunotherapy and individualized follow-up
- Precision Medicine in Hereditary Cancer and Sarcoma; targeted surveillance, immunotherapy and individualized follow-up
Forskningsgrupp
- Urology - urothelial cancer, Malmö
- Health Economics
- Urology
ISBN/ISSN/Övrigt
- ISSN: 0007-0920